Cargando…

Quality Evaluation of Pharmaceutical Formulations Containing Hydrochlorothiazide

Hydrochlorothiazide is a diuretic used to treat hypertension that belongs to class IV of the Biopharmaceutics Classification System. The drug was evaluated by quality control, thermal characterization tests, and pharmaceutical formulation compatibility studies. It was concluded that the generic drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Marcelo Antonio, Yoshida, Maria Irene, da Silva, Daphne Carina Gonçalves Monteiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271651/ https://www.ncbi.nlm.nih.gov/pubmed/25335110 http://dx.doi.org/10.3390/molecules191016824

Ejemplares similares

Thermal Analysis Applied to Verapamil Hydrochloride Characterization in Pharmaceutical Formulations
por: Yoshida, Maria Irene, et al.
Publicado: (2010)

Evaluation of physicochemical properties as supporting information on quality control of raw materials and veterinary pharmaceutical formulations
por: Anacleto, Sara da Silva, et al.
Publicado: (2018)

Electrochemical oxidation behavior of hydrochlorothiazide on a glassy carbon electrode and its voltammetric determination in pharmaceutical formulations and biological fluids
por: Alghamdi, Ali F.
Publicado: (2014)

Unveiling polyamorphism and polyamorphic interconversions in pharmaceuticals: the peculiar case of hydrochlorothiazide
por: Martins, Inês C. B., et al.
Publicado: (2023)

Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form
por: Chikukwa, Mellisa T. R., et al.
Publicado: (2020)

Pharmaceutical Composition of Hydrochlorothiazide:β-Cyclo-dextrin: Preparation by Three Different Methods, Physico-Chemical Characterization and In Vivo Diuretic Activity Evaluation
por: Pires, Maria Arlete Silva, et al.
Publicado: (2011)

The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin
por: Golonka, Iwona, et al.
Publicado: (2020)

Formulation and characterization of hydrochlorothiazide solid lipid microparticles based on lipid matrices of Irvingia fat
por: Agubata, Chukwuma O., et al.
Publicado: (2014)

Design and Optimization of a Chemometric-Assisted Spectrophotometric Determination of Telmisartan and Hydrochlorothiazide in Pharmaceutical Dosage Form
por: Lakshmi, KS, et al.
Publicado: (2010)

Development and Evaluation of an Antimicrobial Formulation Containing Rosmarinus officinalis
por: de Macedo, Lucas Malvezzi, et al.
Publicado: (2022)

Development and Evaluation of Stability of a Gel Formulation Containing the Monoterpene Borneol
por: Dantas, Milla Gabriela Belarmino, et al.
Publicado: (2016)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation
por: Bari, Sanjay, et al.
Publicado: (2010)

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
por: Panzade, Prabhakar, et al.
Publicado: (2017)

Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies
por: da Silva, Rita Y. P., et al.
Publicado: (2023)

Simultaneous Determination of Hydrochlorothiazide and Losartan Potassium in Pharmaceutical Product by UV-Vis Spectrophotometric Method with Kalman Filter Algorithm
por: Binh, Tran Thuc, et al.
Publicado: (2021)

Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
por: Murillo-Fernández, Mac Arturo, et al.
Publicado: (2022)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Hydrochlorothiazide: Hypocalcaemia: case report
Publicado: (2020)

Design and optimization of bilayered tablet of Hydrochlorothiazide using the Quality-by-Design approach
por: Dholariya, Yatin N, et al.
Publicado: (2014)

Evaluation of In Vitro Capsaicin Release and Antimicrobial Properties of Topical Pharmaceutical Formulation
por: Goci, Enkelejda, et al.
Publicado: (2021)

Effects of pharmaceutical formulations containing thyme on carbon tetrachloride-induced liver injury in rats
por: Rašković, Aleksandar, et al.
Publicado: (2015)

Spectrophotometric and chromatographic strategies for exploring of the nanostructure pharmaceutical formulations which contains testosterone undecanoate
por: Butnariu, Monica, et al.
Publicado: (2020)

Application of a Stability-Indicating HPTLC Method for Simultaneous Quantitative Determination of Olmesartan Medoxomil and Hydrochlorothiazide in Pharmaceutical Dosage Forms
por: Ilango, Kaliappan, et al.
Publicado: (2013)

Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007)

Conceptuation, formulation and evaluation of sustained release floating tablets of captopril compression coated with gastric dispersible hydrochlorothiazide using 2(3) factorial design
por: Sirisha, Pathuri Lakshmi, et al.
Publicado: (2014)

FLAVOURING AGENTS IN PHARMACEUTICAL FORMULATIONS
por: Sharma, A. V., et al.
Publicado: (1988)

Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide
por: Sukalo, Aziz, et al.
Publicado: (2016)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Preparation of Hydrochlorothiazide Nanoparticles for Solubility Enhancement †
por: Vaculikova, Eliska, et al.
Publicado: (2016)

Hydrochlorothiazide: Hypokalaemia: 2 case reports
Publicado: (2022)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Phytochemical, Antioxidant, Toxicological, and Pharmaceutical Evaluation of Polyherbal Formulation: Irochel
por: Ghayas, Syma, et al.
Publicado: (2022)

Evaluation of new formulations for neutralizing antimicrobial preservatives in pharmaceutical preparations
por: Katerji, Aya, et al.
Publicado: (2023)

Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation
por: Alshora, Doaa, et al.
Publicado: (2023)

Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
por: Mura, Paola, et al.
Publicado: (2021)

Efficiency of Experimental Formulation Containing Duddingtonia flagrans and Pochonia chlamydosporia against Moniezia expansa Eggs
por: Ribeiro, Giancarlo Bomfim, et al.
Publicado: (2023)

Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2014)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hkdqab6n6djj74n2riisfchs74